4
Views
0
CrossRef citations to date
0
Altmetric
Abstracts

Literature Alerts

Pages 393-408 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Intranasal immunization with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody response. ABRAHAM, E., and SHAH, S., J. Immunol., 1992, 149 (11), 3719–3726.
  • Attachment of 99mTc to lipid vesicles containing the lipophilic chelate dipalmitoyl-phosphatidylethanolamine-DTTA. AHKONG, Q. F., and TubcocK, C., Int. J. Rad. Appl. Inst rum. (B), 1992, 19, (8), 831–840.
  • Antibody-mediated specific binding and cytotoxicity of liposome-entrapped doxorubicin to lung cancer cells in vitro. AHMAD, 1., and ALLEN, T. M., Cancer Res., 1992, 52, (17), 4817–4820.
  • Toxicities of microencapsulated tribromomethane, dibromochloromethane and bromo-dichloromethane administered in the diet to Wistar rats for one month. AIDA, Y., TAKADA, K., UCHIDA, O., YASUIIARA, K., KUROKAWA, Y., and TORE, M., y. Toxicol. Sci., 1992, 17, (3), 119–133.
  • Chronic toxicity of microencapsulated bromodichloromethane administered in the diet to Wistar rats. AIDA, Y., YASUHARA, K., TAKADA, K., KuRoKAwA, Y., and ToliE,Toxicol.Sci., 17, (2), 51–68.
  • Liposome delivery of antisense oligonucleotides: adsorption and efflux characteristics of phosphorothioate oligodeoxynucleotides. AKIITAR, S., and JuLIAN0, R. L.,.7. Controlled Release, 1992, 22, (1), 47–56.
  • Neutron-capture therapy of murine ascites tumor with gadolinium-containing micro-capsules. AK INE, Y. ToKITA, N., TOKUL'YE, K., SAT0H, M., FUKUMORI, Y., Tofu:AnTsc, H., KANAmoiti, R., KOBAYASHI, T., and KANDA, K.,.7. Cancer Res. Clin. Oncol., 1992, 119, (2), 71–73.
  • Microencapsulated latent hardener Novacure for one-part epoxy resin system. AK1YAMA, S., and FITKI.ToKA, M., Kotingu iiho, 191, 15–20.
  • Inhibition of Chlarnydia trachomatis growth in mouse fibroblasts by liposome-encapsulated tetracycline. AL-AwADHI, H., STOKES, G. V., and REICH, M., y. Antimicrob. Chemother., 1992, 30, (3), 303–311.
  • Synthesis and biological studies of new lipid-soluble cisplatin analogues entrapped in liposomes. Al.-BAKER, S., PEREZ-SOLER, R., and KOKHAR, A. R., y. Inorg. Biochem., 1992, 47, (2), 99–108.
  • Study of perturbations induced by the barbiturate, phenobarbital, on DSPC multilamellar liposomes. ALBERTINI, G., DTBINI, B., GORE, L., PoNzi-Bossi, M. O., PRoviNciALI, L., and SIGNoinNo, M., Mol. Cryst. Lig. Cryst. Sci. Technol., Sect. A, 1992, 221, 121–132.
  • Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens. ALVING, C. R., Biochim. Biophys. Acta, 1992, 1113, (3-4), 307–322.
  • Interleukin-2 in liposomes: increased intravenous potency and less pulmonary toxicity in the rat. ANDERSON, P. M., HASZ, D., DICKRE1.1„ L., and SENCER, S., Drug Dev. Res., 1992, 27, (1), 15–31.
  • Depot characteristics and biodistribution of interleukin-2 liposomes: importance of route of administration. ANDERSON, P. M., KATSAN1S, E., SENCER, S. F., HASZ, D., OcH0A, A. C., and BosTRom,Immunother., 1992, 12, (1), 19–31
  • Triggered release of hydrophilic agents from plasmalogen liposomes using visible light or acid. ANDERSON, V. C., and THomrsoN., D. H., Biochim, Biophys. Acta, 1992, 1109, (1), 33–42.
  • Eradication of hepatic metastases of carcinoma H-59 by combination chemoimmunotherapy with liposomal muramyl tripeptide, 5-fluorouracil, and leucovorin. AsAo, T., SHIBATA, H. R., BATIST, G., and BRODT, P., Cancer Res., 1992, 52, (22), 6254–6257.
  • Permeability changes by peroxidation of unsaturated liposomes with ascorbic acid/iron (2+). ASAYAMA, K., ARAMAKI, Y., YOSIIIDA, T., and TsucillYA, S., y. Liposome Res., 1992, 2, (2), 275–287.
  • In vitro stability of liposomes in the presence of polymers, trehalose and sodium tauro-cholate. ASSADULLAIII, T. P., HANI1D, K., and HIDER, R. C., J. Microencapsul., 1992, 9, (3), 317–327.
  • Morphological assessment of hepatoma cells (HepG2) microencapsulated in a HEMA-MMA copolymer with and without Matrigel. BABENSEE, J. E., DE BONI, U., and SEFTON, M. V., Biomed. Mater. Res., 1992, 26, (11), 1401–1418.
  • Liposomal amphotericin-B in the control of aspergillosis: a study on tissue distribution sheds fresh light on directed movement of drug. BACHFIAWAT, B. K., AHMAD, I., and SARKAR, A. K., New Trends Biol. Chem., Japan Sci. Soc. Press, Tokyo, Japan, 1991, pp. 239–247. Ozawa.
  • Quantitation of alveolar distribution of liposome-entrapped antioxidant enzymes. BAKER, R. R., CZOPF, L., JILLING, T., FREEMAN, B. A., KIRK, K. L., and MATALON, S., Am. y. Physiol., 1992, 263, (5, Pt. 1), L585–L594.
  • Partition of piperidinoethylesters of 2-alkyloxyphenylcarbamic acid in unilamellar phos-phatidylcholine liposomes. BALGAVY, P., BENED0wvic, I., KOPECKA, B., and GAI.LovA, J., Gen. Physiol. Biophys., 1992, 11, (3), 269–272.
  • Use of progesterone in microspheres for maintenance of pregnancy in mares. BALL, B. A., WICKER, C., DAELS, P. F., and BURNS, P. J., Am. y. Vet. Res., 1992, 53, (8), 1294–1297. Liposomes: realizing their promise. BANGHAM, A. D., Hosp. Pract. (Off. Ed.), 1992, 27,(12), 51–56. 61–62.
  • Microsphere and dilution techniques for the determination of blood flows and volumes in conscious mice. BARBEE:, R. W., PERRY, B. D., RE, R. N., and MURGO, J. P., Am. y. Physiol., 1992, 263, (3, Pt. 2), R728–R733.
  • Effects of Liposome encapsulated hemoglobin on the reticuloendothelial system. BEACH, M. C., MORLEY, J., SPIRYDA, L., and WEINSTOCK, S. B., Biomater. Artzl. Cells Immobilization Biotechnol., 1992, 20, (24), 771–776.
  • Applicability of dielectric measurements to the adsorption of drugs onto nanoparticles. BENOIT, E., MAINCENT, P., and BESSIERE, J., Int. y. Pharm., 1992, 84, (3), 283–286.
  • Liposome encapsulation prolongs alfentanil spinal analgesia and alters systemic redistri-bution in the rat. BERNARDS, C. M., LUGER, T. J., MALMBERG, A. B., HILL, H. F., and YAKSH, T. L., Anesthesiology, 1992, 77, (3), 529–535.
  • Standardization of process parameters for salbutamol sulphate microcapsules coated with cellulose acetate phthalate and computation of in vitro release kinetics. BHANJA, R. S., and PAL, T. K., Boll. Chins. Farm., 1992, 131, (6), 230–237.
  • Immobilization of active urokinase on albumin microspheres: use of a chemical dehydrant and process monitoring. BHARGAVA, K., and ANDO, H. Y., Pharm. Res., 1992, 9,(6), 776–781.
  • Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems. BODMER, D., KISSEL, T., and TRAECIISLIN, E., 1. Controlled Release, 1992, 21, (1–3), 129–137.
  • Design and mathematical analysis of controlled release from microsphere-containing polymeric implants. BRANNON-PEPPAS, L.,7. Controlled Release, 1992, 20, (3), 201–207.
  • Measurements of cluster-size distributions arising in salt-induced aggregation of polystyrene microspheres. BROIDE, M. L., and COHEN, R. J., j. Colloid Interface Sc,., 1992, 153, (2), 493–508.
  • A flow microsphere inhibition immunoassay (EMI) for detecting paratope binding anti-idiotypic antibodies. BROWN, J. E., and AINSWORTH, A. J., Immunol. Invest., 1992, 21, (6), 565–580.
  • Calcium-mediated interaction between negatively charged and neutral liposomes. BuDKER, V. G., KISELEVA, Kit V., SEREBRYAKOVA, M. V., and St)twi.twr, A. V., FEBS Lett., 1992, 313, (2), 169–172.
  • Liposomes as antigen carriers and adjuvants in vivo. BUITING, A. M. J., VAN ROOIJEN, N., and CI.AASSEN, E., Res. Immunol., 1992, 143, (5), 541–548.
  • In vitro and in vivo responses of doxorubicin ion exchange microspheres to hyperthermia. BURTON, M. A., CHEN, Y., ATKINSON, H., CODDE, J. P., JONES, S. K., and GRAY, B. N., Int. y. Hyperthermia, 1992, 8, (4), 485–494.
  • The macrophage capacity for phagocytosis. CANNON, G. J., and SWANSON, J. A.,]. Cell Sci., 1992, 101, (4), 907–913.
  • The potential of a microencapsulated urease-zeolite oral sorbent for the removal of urea in uremia. CATTANEO, M. V., and CHANG, T. M. S., ASAIO Trans., 1992, 37, (2), 80-87. Hybrid artificial cells: microencapsulation of living cells. CIIANG, 'I'. M., ASA IO y., 1992, 38, (2), 128–130.
  • Immunological effects of hemoglobin, encapsulated hemoglobin, polyhemoglobin, and conju-gated hemoglobin using different immunization schedules. CHANG, T. M., LISTER, C., and NISHIYA, V. R., Biomater. Artif. Cells Immobilization Biotechnol., 1992, 20, (2–4), 611–618.
  • Studies on the entrapment and stability of liposomes containing sulfatide from human brain. CHEN, D., LI, Q. T., and LEE, K. H., Biochem. Int., 1992, 28, (2), 297–304.
  • ph-Sensitive liposomes containing polymerized phosphatidylethanolamine and fatty acid. COOL MYEONG JUN, HAN HYUN SooK, and Kim HYOUNGMAN. y. Biochem. (Tokyo), 1992, 112, (5), 694–699.
  • Automated microparticle enzyme immunoassay for neural thread protein in cerebrospinal fluid from Alzheimer's disease patients. CHONG, J. K., CANTRELL, L., HUSAIN, M., RIESING, S., MILLER, B. E., WANDS, J., DE-LA-MONTE, S., and GHANBARI, H. A., J. Clin. Lab. Anal., 1992, 6, (6), 379–383.
  • Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. CHONN, A., SEMPLE, S. C., and CuLtis, P. R., J. Biol. Chem., 1992, 267, (26), 18759–18765.
  • Formation of unilamellar liposomes from total polar lipid extracts of methanogens. CHOQUET, C. G., PATEL, G. B., BEVERIDGE, T. J., and SPROTT, G. D., Appl. Environ. Microbiol., 1992, 58, (9), 2894–2900.
  • Preparation and evaluation of cellulose acetate microcapsules of diclofenac for sustained release. CHOWDARY, K. P. R., and RATNA, J. V., Indian Drugs, 1992, 29, (11), 494–497.
  • Colored microspheres reveal interarterial microvascular anastomoses in canine myo-cardium. Clcurn, N., RAKUSAN, K., and DOWNEY, H. F., Basic Res. Cardiol., 1992, 87, (4), 400–409.
  • Liposome encapsulated hemoglobin: long-term storage stability and in vivo characterization. CLIFF, R. O., LIGLER, F., GotNs, B., HOFFMANN, P. M., SPIELBERG, H., and RUDOLPH, A. S., Biomater. Artif. Cells Immobilization Biotechnol., 1992, 20, (2-4), 619–626.
  • Efficacy of liposomal amphotericin B (AmBisome) in the eradication of Fusarium infection in a leukaemic patient. COFRANCESCO, E., BOSCHETTI, C., VIVIANI, M. A., BARGIGGIA, C., TOR-TORANO, A. M., CORTELLARO, M., and ZANUSSI, C., Haematologica, 1992, 77, (3), 280–283.
  • The control of the microcapsule wall by energy-dispersive X-ray analysis. COPPI, G., VANDELLI, M. A., FORNI, F., and BERNABEI, M. T., Pharm. Ind., 1992, 54, (3), 293–296.
  • Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. CUVIER, C., ROBLOT-TREUPEL, L., MILLOT, J. M., LIZARD, G., CHEVILLARD, S., MANFAIT, M., COUVREUR, P., and POUPON, M. F., Biochern. Pharmacol., 1992, 44, (3), 509–517.
  • In vitro interaction of interferon-alpha-2b with microsphere particles. CZEJKA, M. J., SCHULLER, J., and MICKSCHE, M., Pharmazie, 1992, 47, (5), 387.
  • Evaluation of mucoadhesive polymers in ocular drug delivery. II. Polymer-coated vesicles. DAVIES, N. M., FARR, S. J., HADGRAFT, J., and KELLAWAY, I. W., Pharm. Res., 1992, 9, (9), 1137–1144.
  • Binding characteristics and thermal behaviour of cytochrome-C oxidase, inserted into phospholipid-coated, magnetic nanoparticles. DE CUYPER, M., and JoNtAu, M., Biotechnol. Appl. Biochem., 1992, 16, (2), 201–210.
  • Large unilamellar vesicle liposomes for wool dyeing: stability of dye-liposome systems and their application on untreated wool. DE LA MAZA, A., PARRA, J. L., Boscii, P., and CODERCH, L., Text. Res. .7., 1992, 62, (7), 406–413.
  • Alteration of permeability of neutral and electronegatively charged liposomes by alkyl sulfate surfactants. DE LA MAZA, A., PARRA, J. L. and SANCHEZ-LEAL, J., Langmuir, 1992, 8, (10), 2422–2426.
  • Absorption of chloramphenicol encapsulated in liposomes through rabbit cornea. DE LAVAL, W., WOYCZIKOWSKI, B., Szui.c, J., and JANICKI, S., Farm. Pol., 1992, 48, (5-6), 359–361.
  • Influence of beef tallow and muscle on the antilisterial activity of pediocin AcH and liposome-encapsulated pediocin AcH. DEC;NAN, A. J., and LUCHANSKY, J. B., y. Food Prot., 1992, 55, (7), 552–554.
  • Preparation, properties and biological function of liposome encapsulated hemoglobin. DOMOKOS, G., JoPsxt, B., and SCHIVIIDT, K. H., Biomater. Artif. Cells Immobilization Biotechnol., 1992, 20, (2-4), 345–354.
  • Interactions of liposome encapsulated hemoglobin and phosphate buffer liposomes with neutrophilic granulocytes and plasma. DomoKos, G., TAUBER, G., and SCHMIDT, K. H., Biomater. Artif. Cells Immobilization Biotechnol., 1992, 20, (2-4), 761–770.
  • Poly(4-vinylpyridine)-coated liposomes: stability studies and release of acetylsalicylic acid (ASA). DONG, C., and ROGERS, J A., y. Microencapsul., 1992, 9, (4), 437–448.
  • Composition of cell wall microcapsules manufactured from Chenopodium album cell walls. DONGOWKSI, G., EIDVALD, R., LUCK, K., and STOOF, G., Phytochemistry, 1992, 31, (9), 3039–3042.
  • Topical delivery of liposomally encapsulated gamma-interferon. DU PLESSIS, J., EGBARIA, K., RAMACHANDRAN, C., and WEINER, N., Antiviral Res., 1992, 18, (3-4), 259–265.
  • Influence of formulation factors on the deposition of liposomal components into the different strata of the skin. Du PLEssis, L., EGBARIA K., and WEINER,Soc. Cosmet. Chem., 1992,43, (2), 93–100.
  • Improvement of a microencapsulation with aqueous core by factorial design. DuFouR, P., BRUN, H., CHAPELON, R., and PouvET, B., 7. Microencapsul., 1992, 9, (4), 465–468.
  • Microspheres as a nasal delivery system for peptide drugs. EDMAN, P., BJOERK, E., and RYDEN, L., Y. Controlled Release, 1992, 21, (1-3), 165–172.
  • Cell wall microcapsules with different porosity from suspension cultured Chenopodium album. EnwAI,D, R., WOEHLECKE, H., and 'EITEL, C., Phytochemistry, 1992, 31, (9), 3033–3038.
  • Preparation and in vitro evaluation of slow release ketoprofen microcapsules formulated into tablets and capsules. El, KHODAIRY, K. A., ESHRA, A. G., NADA, A. H., and MORTADA, S. A., J. Microencapsul., 1992, 9, (3), 365–373.
  • Biodegradable poly(m-lactide-co-glycolide) microspheres. ELDRIDGE, J. H., STAAS, J. K., TicE, 1'. R., and GILLEY, R. M., Res. Immunol., 1992, 143, (5), 557–563.
  • Liposomal amphotericin B in the treatment of candida infection in a 3-month-old infant. EMMINGER, W., INNERHOFER, A., HELFERT, A., KUMMER, M., and GADNER, H., Padiatr, Padol., 1992, 27, (4), 97–99.
  • Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. ESPARZA, I., and KISSEI,, T., Vaccine, 1992, 10, (10), 714–720.
  • Liposomes-model membranes to study the binding of tricyclic antidepressants. FISAR, Z., KRULIK, R., and BEITIAWA, D., Drug Metab. Drug Interact., 1991, 9, (3-4), 269–281.
  • An investigation of internal phase losses during the microencapsulation of fragrances. FLORES, R. J., WALL, M. D., CARNAHAN, D. W., and °ROPING, T. A., y. Microencapsul., 1992, 9, (3), 287–307.
  • Effect of nanoparticle-bound ampicillin on the survival of Listeria monocytogenes in mouse peritoneal macrophages. FORESTIER, F., GEI2RIER, P., CHAUMARD, C., QUER°, A. M., COUVREUR, P., and LABARRE, C.,,7. Antimicrob. Chemother., 1992, 30, (2), 173–179.
  • Scanning topography of phospholipid bilayers and vesicles (liposomes) by scanning tunneling microscopy (STM). FOWLER, K., BOTTOMLEY, L. A., and SCHREIER, H., y. Controlled Release, 1992, 22, (3), 283–291.
  • A statistical analysis of flow cytometric determinations of phagocytosis rates. FREDRR2KsoN, A. G., HATZIS, C., and SRIENC, F., Cytometry, 1992, 13, (4), 423–431.
  • Polyacrylate resin microcapsules for taste masking of antibiotics. FRIEND, D. R., y. illicroencapsul., 1992, 9, (4), 469–480.
  • Fibrin-enmeshed tobramycin liposomes: single application topical therapy of Pseudomonas keratitis. FRUCHT-PERRY, J., ASSIL, K. K., ZIEGLER, E., DouGLAs, H., BROWN, S. I., SCHANZIAN, D. J., and WEINREIB, R. N., Cornea, 1992, 11, (5), 393–397.
  • Hemolytic activity of a dental adhesive monomer (N-methacryloyloxy-5-aminosalicylic acid, MASA) and its interaction with phospholipid liposomes as studied by NMR and DSC. FujisAwA, S., KomoDA, Y., and KADONIA, Y., Dent. Mater. .7., 1992, 11, (1), 17–25.
  • Internal volume determination of liposomes by a rapid equilibrium technique using hydrogen iodide as a marker. FURNIAN, A., and SAYGIN, O., Biotechnol. Tech., 1992, 6, (4), 299–304.
  • Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production. GASI'AR, R., PREAT, V., OPPERDOES, F. R., and ROLAND, M., Pharm. Res., 1992, 9, (6), 782–787.
  • Enhancement of the penetration of dithranol and increase of effect of dithranol on the skin by liposomes. GEHRING, W., GHYCZY, M., GLOOR, M., SCHEER, T., and RoDING, J., Arzneimittelforschung, 1992, 42, (7), 983–985.
  • Effect of cisplatin, carboplatin and stobadine on lipid peroxidation of kidney homogenate and phosphatidylcholine liposomes. GERGEL, D., MISIK, V., and ONDRIAS, K., Physiol. Res. (Prague), 1992, 41, (2), 129–134.
  • Computer simulation for diffusional kinetics of drug from polymer-coated microcapsules. CilmsAl., S. K., DAs, S., TAIATKDAR, P., and PAL, T. K., Hung. J. Ind. Chem., 1992, 20, (3), 183–187.
  • Liposome shrinkage and swelling under osmotic-diffusional stress: evaluation of kinetic parameters from spectrophotometric measurements. Gliosii, P., and SINGH, U. N., Biochim. Biophys. Acta, 1992, 1110, (1), 88–96.
  • Peritoneal exudates from microencapsulated rat islets of Langerhans xenografted mice presenting characteristics of potentially cytotoxic nonspecific inflammation. GIN, H., CADIC, C., BAQUEY, C., and Dt Tut', B., y. Microencapsul., 1992, 9, (4), 489–494.
  • Use of ultrasonic and microsphere techniques to evalute regional aspects of vasodilator therapy in myocardial ischaemia, arterial hypertension and heart failure. GUIDICELLI, J. F., BERDEAUX, A., RICHER, C., and THUILLEZ, C., y. Hypertens., suppt., 1992, 10, (5), S29–S36.
  • Biological evaluation of pesticides released from temperature-responsive microcapsules. GREENE, L. C., MEYERS, P. A., SPRINGER, J. T., and BANKS, P. A., y. Agric. Food Chem., 1992, 40, (11), 2274–2278.
  • Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen. GREGORIADIS, G., TAN, L., BEN-AHMEIDA, E. T., and jENNINGS, R., Vaccine, 1992, 10, (11), 747–753.
  • Destabilization of pH-sensitive liposomes in the presence of human erythrocyte ghosts. GREIDZIAK, M., BOGDANOV, A. A., TORCHILIN, V. P., and LASCH, J.,y. Controlled Release, 1992, 20, (3), 219–229.
  • Incorporation of an antineoplastic drug aclarubicin into liposomes in relation to the conditions of its encapsulation. GRIAZNOVA, N. S., PETIUSHENKO, R. M., BELIANSKA1A, I. V., SABUROVA, L. A., SAZYKIN, Jr O., and NAVASHIN, S. M., Antibiot. Khimioter., 1992, 37, (4), 22–25.
  • Obtaining liposomal preparations of various biologically active substances by the method of detergent flow analysis. GRIAZNOVA, N. S., PETIUSHENKO, R. M., BELIAVSKA1A, I. V., BEREZOVSKAIA, L. N., ZFIUKOV, V. G., SVIR1DOV, B. D., SAZYKIN, Jr O., and NAVASHIN, S. M., Antibiot. Khimioter., 1992, 37, (7), 3–8.
  • The effect of aging on the physical stability of liposome dispersions. GRIT, M., and CROMMELIN, D. J., Chem. Phys. Lipids, 1992, 62, (2), 113–122.
  • Microencapsulation of hybridomas by cellulose sulfate-polydimethyldiallylammonium chloride procedure. GROOT-WASSINK, T., DAUTZENBERG, H., GRUNOW, R., and VON BAEHR, R., Acta Biotechnol., 1992, 12, (3), 169–178.
  • Phospholipid vesiculated fluorocarbons-promising trend in blood substitutes. GROSS, U., RUDIGER, S., REICHELT, H., and DRAFFEHN, J., Biomater. Art if. Cells Immobilization Biotechnol., 1992, 20, (2-4), 831–833.
  • Incorporation of aclarubicin, an antitumor antibiotic, into liposomes in relation to encap-sulation conditions. GRYAZNOVA, N. S., PETYLISHENKO, R. M., BELYAVSKAYA, I. V., SABUROVA, L. A., SAZYKIN, YU O., and NAVASHIN, S. M., Antibiot. Khimioter., 1992, 37, (4), 22–25.
  • Biodegradable block copolymer matrixes for long-acting contraceptive with constant release. GU-ZHONGWE1, YE-WEIPING, YANG-JIYUAN, LI-YOUXIN, CHEN-XIANLI, ZILONG-GEWEN, and FENG-XINDE, y. Controlled Release, 1992, 22, (1), 3–14.
  • Effects of liposomal gentamicin on bacteria in human phagocytes. GUBENKO, L. V., GULYAEV, A. YE, and KIVMAN, G. YA., Khim. Farm. Zh., 1992, 26, (4), 35–38.
  • Features of liposome-incorporated rifampicin after its intratracheal administration in rats. GURF.VICH, G. L., BEREZOVSKAYA, L. N., and MANUILOV, K. K., Antibiot. Khimioter., 1992, 37, (7), 25–28.
  • Toxicity of a new dosage format, cisplatin incorporated in lactic acid oligorner microspheres, in mice. HAG1WARA, A., TAKAHASHI, T., SASABE, T., Ero, M., LEE, M., SAKAKURA, C., SHOBAYASHI, S., MURANISHI, S., and TASHIMA, S., Anticancer Drugs, 1992, 3, (3), 237–244.
  • Non-Michaelis-Menten type hepatic uptake of liposomes in the rat. HARASHIMA, H., KUME, Y., YAMANE, C., and KIWADA, H., j. Pharm. Pharmacol., 1992, 44, (9), 707–712.
  • In vivo evaluation of the effect of the size and opsonization on the hepatic extraction of liposomes in rats: an application of Oldendorf method. HARASHIMA, H., OHN1sHI, Y., and KIWADA, H., Biopharm. Drug Dispos., 1992, 13, (7), 549–553.
  • Detection of antithyroglobulin autoantibodies with defined epitopic specificity by a micro-particle-enhanced nephelometric immunoassay. HARCHALI, A. A., MONTAGNE, P., CUILLIERE, M. L., BOUANANI, M., PALI, B., and DIAIRILLE, J., Clin. Chem., 1992, 38, (9), 1859–1864.
  • In vitro and in vivo evaluation of sustained-release and enteric-coated microcapsules of diclofenac sodium. HASAN, M., NAJIB, N., SULEIMAN, M., EI-SAYED, Y., and ABDEL-HAM1D, M., Drug. Dev. Ind. Pharm., 1992, 18, (18), 1981–1988.
  • Stimulation of human T cells by sparse antigens captured on immunomagnetic particles. HAWKE, S., WILLCOX, N., HARCOURT, G., VINCENT, A., and NEwsom-DAVIS, J., J. Immunol. Methods, 1992, 155, (1), 41–48.
  • M13 single-strand purification using a biotinylated probe and streptavidin coated magnetic beads. HAWKINS, 'F., DNA Seq., 1992, 3, (2), 65–69.
  • Development of a procedure for coupling the homing device gluplasminogen to liposomes. HEEREMANS, J. L., KRAA1JENGA, J. J., Los, P., KLUFT, C., and CROMMEL1N, D. J., Biochim. Biophys. Acta, 1992, 1117, (3), 258–264.
  • Is liver to lung shunting in colorectal liver metastasis the cause of toxicity following treatment with cytotoxic microsphere aggregates? HENNIGAN, T. W., EARLAM, S., and ALLEN-MERSH, T. G., Br. y. Cancer, 1992, 66, (6), 1169–1170.
  • Removal of endotoxin from culture supernatant of Bordetella pertussis with aminated poly(gamma-methyl L-glutamate) spherical beads. HIRAYAMA, C., SAKATA, M., OHKURA, Y., IHARA, H., and OHKUMA, K., Chem. Pharm. Bull., 1992, 40, (8), 2106–2109.
  • Application of non-porous silica ultramicrospheres to high-performance liquid chroma-tographic column packings. HONDA, F., HONDA, H., and KOISHI,Chromatogr., 1992,609, (1-2), 49–59.
  • Retrograde labeling of lumbosacral interneurons following injections of red and green fluorescent microspheres into hindlimb motor nuclei of the cat. HOOVER, J. E., and DURKOVIC, R. G., Somatosens. Mot. Res., 1992, 9, (3), 211–226.
  • In vitro cytotoxicity of liposome-encapsulated doxorubiciii: dependence on liposome composition and drug release. HOROWITZ, A. T., BARENHOI,Z, Y., and GABIZON, A. A., Biochim. Biophys. Acta, 1992, 1109, (2), 203–209.
  • Preparation and characterization of antibodies against Bungarus multicinctus venom by liposomes. Hsu, J. C., CIWANG, L. Y., and CHANG, C. C., Kao Hsiung i Hsueh Ko Hseuh Tsa Chih, 1992, 8, (6), 320–326.
  • Microscopic localization of sterically stabilized liposomes in colon carcinoma-hearing mice. HUANG, S. K., LEE, K. D., HONG, K., FRIEND, D. S., and PAPAHADJOPOULOS, D., Cancer Res., 1992, 53, (19), 5135–5143.
  • Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. HUANG, S. K., MAYHEW, E., GILANI, S., LASIC, D. D., MARTIN, F. J., and PAPAHADJOPOULOS, D., Cancer Res., 1992, 52, (24), 6774–6781.
  • Liposome mediated affection of monocytes. HurriNGA, 1., DAmoisEaux, J. C., VAN ROOIJEN, N., DOPP, E. A., and DIJKSTRA, C. D., Immunobiology, 1992, 185, (1), 11–19.
  • Microspheres for nasal administration. ILLum, L., and DAVIS, S. S., Buccal Nasal Adm. Altern. Parenter. Adm., Minutes Eur. Symp., Ed. Sante, Paris, Fr., 1992, pp. 125–137. Ed.: Duchene, D.
  • Antioxidative activity of arbutin in solution and liposomal suspension. IoKu, K., TERAO, J., and NAKATANI, N., Biosci., Biotechnol., Biochem., 1992, 56, (10), 1658–1659.
  • Current development of the problem of 'artificial blood'. IvANov, K. P., Gematol. Transfuziol., 1992, 37, (2), 26–29.
  • Allograft of microencapsulated islets in agarose gel in streptozotocin-induced and nonobese diabetic mice. IWATA, H., TAKAGI, T., YAMASHITA, K., KOBAYASHI, K., and AMEMIYA, H., Transplant. Proc., 1992, 24, (3), 934.
  • Antioxidant activities of alpha-tocopherol and hydroxycarbazole against lipid peroxidation in homogeneous solution and in liposomal membranes. IwATsuxi, M., NIKI, E., KATO, S., and NISHIKORI, K., Chem. Lett., 1992, (9), 1735–1738.
  • Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. JAN', P. U., FLORENCE, A. T., and MCCARTHY, D. E., Int. J. Pharm., 1992, 84, (3), 245–252.
  • Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics. JANKNEGT, R., DE MARIE, S., BAKKER-WOUDENBERG, I. A., and CROMMELIN, D. J., Clin. Pharmacokinet., 1992, 23, (4), 279–291.
  • Inclusion and fractionated release of nucleic acids using microcapsules made from plant cells. JASCHKE, A., CECH, D., and EHWALD, R., y. Chromatogr., 1992, 596, (2), 165-171. Liposomes as a drug delivery system for antisense oligonucleotides. JULIANO, R. L., and AKFITAR, S., Antisense Res. Dev., 1992, 2, (2), 165–176.
  • A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks. JUST, M., BERGER, R., DRESCHSLER, H., BRANTSCHEN, S., and GLUCK, R., Vaccine, 1992, 10, (11), 737–739.
  • Tissue reaction after intramuscular injection of liposomes in mice. KADIR, F., ELING, W. M., ABRAHAMS, D., ZUIDEMA, J., and CROMMELIN, D. J., Int. Clin. Pharmacol. Ther. Toxicol., 1992, 30, (10), 374–382.
  • Influence of liposome preparation conditions and schedules of treatment of A/HeJ mice bearing A-1 tumors with liposome-encapsulated cisplatin upon antitumor activity and toxicity. KALEDIN, V. I., POPOVA, N. A., NIKOLIN, V. P., and STETSENKO, A. I., Eksp. Onkol., 1992, 14, (2), 60–64.
  • Liposomal cisplatin distribution and general toxicity in A/HeJ mice. KALEDIN, V. I., STETSENKO, A. I., TSYMBALIST, V. G., POPOVA, N. A., and NIKOLIN, V. P., Eksp. Onkol., 1992, 14, (1), 69–72.
  • Concepts on the use of liposomal antimicrobial agents: applications for aminoglycosides. KARLOWSKY, J. A., and ZHANEL, G. G., Clin. Infect. Dis., 1992, 15, (4), 654–667.
  • Hg2+ and Cu* are ionophores, mediating Cl - /OH - exchange in liposomes and rabbit renal brush border membranes. KARNISKI, L. P., y. Biol. Chem., 1992, 267, (27), 19218–19225.
  • Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyiso-hexylcyanoacrylate nanoparticles. KATTAN, J., DROZ, J. P., COUVREUR, P., MARINO, J. P., BOUTAN-LAROZE, A., ROUGIER, P., BRAULT, P., VRANCKX, H., GROGNET, J. M., MORGE, X. et al., Invest. New Drugs, 1992, 10, (3), 191–199.
  • Hexadecylphosphocholine in liposomal dispersions. KAUFMANN-KOLLE, P., UNGER, C., and EIBL, H., Prog. Exp. Tumor Res., 1992, 34, 12–24.
  • Preparation of powdered phospholipid nanospheres by spray drying in an aqueous system with sugars. KAWASHIMA, Y., HIND, T., TAKEUCHI, H., NIWA, T., KAWAKATSU, E., KAYANO, M., IDA, K., and OZAWA, H., Chem. Pharm. Bull., 1992, 40, (7), 1911–1916.
  • Toxicity and efficacy studies on a series of lipid-soluble dineodecanoato(trans-R,R- and trans-S,S-1,2-diaminocyclohexane) platinum(II) complexes entrapped in liposomes. KHOKHAR, A. R., AL-BAKER, S., and PEREZ-SOLER, R., Anticancer Drugs, 1992, 3, (2), 95–100.
  • Laser-induced experimental vascular occlusion using liposome-encapsulated ADP. KHOOBEH I, B., PEYMAN, G. A., BHATT, N., and MOSHFEGHI, D., Lasers Surg. Med., 1992, 12, (6), 609–614.
  • Injectable microspheres with controlled drug release for glaucoma filtering surgery. KIMURA, H., OGURA, Y., MORITERA, T., HONDA, Y., WADA, R., HYON, S. H., and IKADA, Y., Invest. Ophthalmol. Vis. Sc., 1992, 33, (12), 3426–3441.
  • Lysis of rabbit gamma-globulin-coupled liposomes by the complement system. KISHIMURA, M., FUKUDA, H., KATOH, S., SADA, E., and TANIGUCHI, H.J. Ferment. Bioeng., 1992, 74, (2), 81–84.
  • Advantages of liposomal forms of chemotherapeutical agents over conventional ones in showing effects on intracellular bacteria: pharmacokinetics, efficiency (a review). KIVMAN, G. YA, GULYAEV, A. E., and GUBENKO, L. V., Khim. Farm. Zh., 1992, 26, (6), 4–8.
  • Suppressive effects of FTS on alloxan-induced diabetes and their prolongation by using lipo-somes. KOJIMA, S., KUBOTA, K., AWAYA, A., YUDA, T., MARUYAMA, K., and IWATSURU, M., Drug Delivery Syst., 1992, 7, (5), 357–361.
  • Lipid-heme microsphere. A new totally synthetic oxygen-carrier under physiological conditions. KOMATSU, T., MATSUBUCHI, E., NISHIDE, H., and TSUCHIDA, E., Chem. Lett., 1992, (7), 1325–1328.
  • Affinity purification of antibodies using immunomicrospheres. RONDO, A., YAMASAKI, R., and HIGASHITANI, K., Ferment. Bioeng., 1992, 74, (4), 226–229.
  • Effect of liposomal interleukin-2 on ascites-forming rat hepatoma. KONNO, H., MARUP, Y., MATIN, A. F., TANAKA, T., NAKAMURA, S., BABA, S., YAMASHITA, A., and TADAKUMA, T., .7. Surg. Oncol., 1992, 51, (1), 33–37.
  • Leakage of a trapped fluorescent marker from liposomes: effects of eutectic crystallization of NaCI and internal freezing. KRISTIANSEN, J., Cryobiology, 1992, 29, (5), 575–584.
  • Automated homogeneous liposome immunoassay systems for anticonvulsant drugs. KUBOTSU, K., GOTO, S., FUJITA, M., TUCHIYA, H., KIDA, M., TAKANO, S., MATSUURA, S., and SAKURABAYASHI, I., Clin. Chem., 1992, 38, (6), 808–812.
  • Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging. KUNIMASA, J., INui, K., HOE, R., KAWAMURA, Y., and ENDO, K., Chem. Pharm. Bull., 1992, 40, (9), 2565–2567.
  • Release of proteins via ion exchange from albumin-heparin microspheres. KWON, G. S., BAR-YOU-HAN, CREMERS, H., FEIJEN, J., and KIM-SuNG-WAN., y. Controlled Release, 1992, 22, (2), 83–93.
  • Phospholipid liposome fusion by the fluorescent probe method. KWON-KYUNG-OK, ABE, M., KIM-MYUNG-JA, and OGINO, K., Yukagaku, 1992, 41, (6), 501–506.
  • Liposomes-biomembrane model, pharmaceutical and vaccines carrier. LASCH, J., and WEISSIG, V., CLB Chem. Labor. Biotech., 1992, 43, (5), 249–250. 252.
  • Gelation of liposome interior. A novel method for drug encapsulation. LASIC, D. D., FREDERIK, P.M., STUART, M. C. A., BARENHOLZ, Y., and MCINTOSH, T. J., FEBS Lett., 1992, 312, (2-3), 255–258.
  • Preparation and the mechanism of liposome formation. LASIC, D. D., and MARTIN, F. LI. Surf Sci. Technol., 1991, 7, (4), 291–305.
  • Measurement of rat lung blood flow with labelled microspheres. LATRES, E., CLOSA, D., GOMEZ-SIERRA, J. M., ALEMANY, M., and REMESAE, X., Arch. Int. Physiol. Biochim. Biophys., 1992, 100, (3), 263–265.
  • A method for attachment of peptides to a solid surface with enhanced immunoreactivity. LEAHY, D. C., SHAH, D. O., and TODD, J. A., Biotechniques, 1992, 13, (5), 738–743.
  • Induction of vesicle-to-micelle transition by bile salts for DOPE vesicles incorporating immunoglobulin G. LEE-EuN-Ox, Kim-JIN-Gu, and KIM-JDNG-DuK, y. Biochem. (Tokyo), 1992, 112, (5), 671–676.
  • Evidence that the scavenger receptor is not involved in the uptake of negatively charged liposomes by cells. LEE, K. D., PITAS, R. E., and PAPAHADJOPOULOS, D., Biochim. Biophys. Acta, 1992, 1111, (1), 1–6.
  • Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: compari-son with cationic liposomes. LEGENDRE, J. Y., and SZOKA, F. C. JR., Pharm. Res., 1992, 9, (10), 1235–1242.
  • Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes. LEGRAND, P., RomER0, E. A., ComN, B. E., and BOLARD, J., Antimicrob. Agents Chemother., 1992, 36, ((1), 2518–2522.
  • Alkyl cyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain lengths. LHERM, C., MULLER-RAINER, H., PUISIEUX, F., and COUVREUR, P., Int. 1. Pharm., 1992, 84, (1), 13–22.
  • Calcium alginate beads as core carriers of 5-aminosalicylic acid. LIN, S. Y., and AYRES, J. W., Pharm. Res., 1992, 9, (9), 1128–1131.
  • Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen. LITZINGER, D. C., and HUANG, L., Biochim. Biophys. Acta, 1992, 1127, (3), 249–254.
  • Preparation of gentamycin-bearing microcapsules. Liu-BAOSHAN, YU-XIQUAN, HUANG-X IAOFENG, and ZHANG-JINCAl. Zhongguo Yaoxue Zazhi, 1992, 27, (7), 408–410.
  • Preparation of liposomes entrapping plasmid DNA and linear DNA. LIU, Q. Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao, 1992, 14, (3), 220–224.
  • A comparison of glycine, sarcosine, N,N-dimethylglycine, glycinebetaine and N-modified betaines as liposome cryoprotectants. LLOYD, A. W., BAKER, J. A., SMITH, G., OLLIFF, C. J., and ReTT, K. J., y. Pharm. Pharmacol., 1992, 44, (6), 507–511.
  • Preparation and physical evaluation of microcapsules of hydrophilic drug-cyclodextrin com-plexes. LorrssoN, T., KRISTMUNDSDOTTIR, T., INGVARSDOTTIR, K., OLAFSDOTTIR, B. J., and BALD VINSDOTTIR, J.,.7. Microencapsul., 1992, 9, (3), 375–382.
  • Microencapsulation in Na-alginate and in vitro development of sheep blastomeres. Loi, P., LEDDA, S., GALLUS, M., FILIA, F., CAPPAI, P., and NAITANA, S., Boll. Soc. Ital. Biol. Sper., 1992, 68, (5), 311–314.
  • Reduction of cardiovascular side effects associated with ocular administration of meti-pranolol by inclusion in polymeric nanocapsules. LosA, C., ALONSO, M. J., VILA, J. L., ORALLO, F., MARTINEZ, J., SAAVEDRA, J. A., and PASTOR, J. C.,y. Ocul. Pharmacol., 1992, 8,(3), 191–198.
  • Acrylic acid copolymer nanoparticles for drug delivery: I. Characterization of the surface properties relevant for in vivo organ distribution. LUKOWSKI, G., MUELLER, R. H., MUELLER, B. W., and DITTGEN, M., Int. y. Pharm., 1992, 84, (1), 23–31.
  • Bulk organic solvent-water systems as a possible model to predict alkyl p-aminobenzoate partitioning in liposomes. MA, L., RAMACHANDRAN, C., and WEINER, N.Pharm. Sci.,1992, 81, (11), 1104–1108.
  • Enhancing potency of liposomal monensin on ricin cytotoxicity in mouse macrophage tumor cells. MADAN, S., and GHOSII, P. C., Biochem. Int., 1992, 28, (2), 287–295.
  • Monensin intercalation in liposomes: effect on cytotoxicities of ricin, Pseudomonas exotoxin A and diphtheria toxin in CHO cells. MADAN, S., and GlIOSH, P. C,, Biochim. Biophys. Acta, 1992, 1110, (1), 37–44.
  • Permeability of insulin entrapped in liposome through the nasal mucosa of rabbits. MAITANI, Y., AsAm), S., TAKAHASHI, S., NAKAGAKI, M., and NAGAI, T., Chem. Pharm. Bull., 1992, 40, (6), 1569–1572.
  • Initial characterization of the metabolism of intervertebral disk cells encapsulated in micro-spheres. MALDONADO, B. A., and OEGEMA, T. R. JR., y. Orthop. Res., 1992, 10, (5), 677-690. Phagocytosis of liposomes by human platelets. MALE, R., VANN IER, W. E., and BALDESCHWIELER, J. D., Proc. Natl. Acad. Sci. USA, 1992, 89, (19), 9191–9195.
  • Microencapsulation of terbutaline sulfate by the solvent evaporation technique. MANEKAR, N. C., PHRANIK, P. K., and JOSH, S. By. microencaps.t., 1992, 9, (4), 481–487.
  • Synthesis of new hydrophilic microspheres: optimized carriers for microparticle-enhanced nephelometric immunoassays. MARCHAND, J., VARCIN, P., RIOCHET, D., MONTAGNE, P., CUILLIERE, M. L., DUHEILLE, J., and PAU, B., Biopolymers, 1992, 32, (8), 971–980.
  • Propyl gallate on liposomes. MARSTON, S., Contact Dermatitis, 1992, 27, (2), 74–76.
  • On some aspects of the adsorption of immunoglobulin-G molecules on polystyrene microspheres. MARTIN, A., Pula, J., GALISTEO, F., SERRA, J., and HIDALGO-ALVAREZ, R., 1. Dispersion Sci. Technol., 1992, 13, (4), 399–416.
  • Prolonged circulation time in vivo of large unilamelar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol).
  • MARUYAMA, K., YuDA, T., OKAm(m), A., KOJIMA, S., SUGINAKA, A., and IwATsuat:, M., Biochim. Biophys. Ada, 1992, 1128, (1), 44–49.
  • Ganglioside GM1-liposomes with prolonged circulation times as carriers of adriamycin.
  • MAIWYAMA, K., OKAMOTO, A., K0.11mA, S., SUGINAKA, A., and IWATSURU, M., Drug Delivery Syst., 1992, 7, (5), 345–350.
  • Determination of size and structure of lipid IVA vesicles by quasi-elastic light scattering and small-angle x-ray scattering. MAURER, N., and GLATTER, O., Springer Proc. Phys., 1992, 66 (Struct. Conform. Amphiphilic Membr.), 193–197.
  • Microencapsulated nerve growth factor: effects on the forebrain neurons following devascu-larizing cortical lesions. MAYSINGER, D., JALsENJAK, I., and CuEL1A), A. C., Neurosci. Lett., 1992, 140, (1), 71–74.
  • Drug targeting systems for antiviral agents: options and limitations. MEIJER, D. K., JANSEN, R. W., and MOLEMA, G., Antiviral Res., 1992, 18, (3-4), 215–258.
  • Effect of phosphatidylcholine cholesterol liposomes on the growth of bacterial cultures. MELIANTSEVA, L. P., KREINES, V. M., MECNIKOVA, V.M., and GLADSHTEIN, A. I., Antibiot. Khimioter., 1992, 37, (1), 14–17.
  • Roles of peripheral leukocytes and tissue macrophages in antibacterial resistance induced by free or liposome-encapsulated muramyl tripeptide phosphatidylethanolamide. MELISSEN, P. M., VAN VIANEN, W., and BAKKER-WOUDENBERG, I. A., Infect. Immun., 1992, 60, (11), 4891–4897.
  • Effect of liposomes on percutaneous penetration of lipophilic materials. MICHEL, C., PURMANN, T., MENTRUP, E., SEILLER, E., and KREUTER, J., Int.J. Pharm., 1992, 84, (2), 93–105.
  • Preparation of a microcapsule using the crystallization of the particles of a dispersion and the study of their permeability. MIKHALEV, O. I., SERPINSKI, M., POPOV, V. I., and ALFIMOV, M. V., Zh. Fiz. Khim., 1992, 66, (3), 776–781.
  • Interferon production of L929 and HeLa cells enhanced by polyriboinosinic acid-polyribo-cytidylic acid pH-sensitive liposomes. MILHAUD, P. G., COMPAGNON, B., BIENVENUE, A., and PHILIPPOT, J. R., Bioconjug. Chem., 1992, 3, (5), 402–407.
  • On the interaction of the liposomal membrane with blood components. MILLER, I. F., H0AG, J. M., and ROONEY, M. W., Biomater. Artif. Cells Immobilization Biotechnol., 1992, 20, (2-4), 627–634.
  • Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes. MILLER, M. D., GouLD-F0GEttiTE, S., SHEN, L., WOODS, R. M., KOENIG, S., MANNINO, R. J., and LETVIN, N. L., j. Exp. Med., 1992, 176, (6), 1739–1744.
  • Compression-expansion curves of poly(m-lactic acid-co-glycolic acid) monolayers. MINONES, J., IRIBARNEGARAY, E., VARELA, C., VILA, N., CoNDE, O., Cm., L., and CASAS, M., Langmuir, 1992, 8, (11), 2781–2784.
  • Morphological changes in liposomes caused by polymerization of encapsulated actin and spontaneous formation of actin bundles. MIYATA, H., and HOTANI, H., Proc. Natl. Acad. Sci. USA, 1992, 89, (23), 11547–11551.
  • Dependence of pH of permeability towards electrolyte ions of poly(L-lysine-alt-terephthalic acid) microcapsule membranes. MIYAUCHI, E., ToGAwA, Y., MAKIN0, K., OHSHIMA, H., and KONDO,Microencapsul., 1992, 9, (3), 329–333.
  • Purification and quantitative determination of carboxymethylchitin incorporation into submicron bilayer-lipid membrane artificial cells (liposomes) encapsulating hemoglobin. MoBED, M., and CHANG, T. M., Biomater. Artif. Cells Immobilization Biotechnol., 1992, 20, (2-4), 369–376.
  • Preparation of carboxymethylchitin-incorporated submicron bilayer-lipid membrane artificial cells (liposomes) encapsulating hemoglobin. MOBED, M., NISHIYA, T., and CHANG, T. M., Biomater. Artif. Cells Immobilization Biotechnol., 1992, 20, (2-4), 365–368.
  • The control of ethyl cellulose microencapsulation using solubility parameters. MOLDENHAUER, M. G., and NAIRN, J. G., J. Controlled Release, 1992, 22, (3), 205–218.
  • Kinetics and activity distribution of urease coencapsulated with hemoglobin within polyamide membranes. MoNsmEoum, M., and NELIFELD, R. J., Appl. Biochem. Biotechnol., 1992, 32, 111–126.
  • Use of microsphere-antibody conjugates in microparticle-enhanced nephelometric immunoassay. MONTAGNE, P., El. OMARI, R., CLIQUE', F., CUILLIERE, M. L., and DUHEILLE, J., Bioconjug. Chem., 1992, 3, (6), 504–509.
  • Liposomal hamycin in the control of experimental aspergillosis in mice: relative toxicity, therapeutic efficacy and tissue distribution of free and liposomal hamycin. MOON IS, M., Ai imAD, I., and BACHHAWAT, B. K., Indian j. Biochem. Biophys., 1992, 29, (4), 339–345.
  • Liposomes as carriers of boronated thiouracils for NCT of melanoma. MOORE, D. E., CHANDLER, A. K., CoRDER0Y, B. S., WILSON, J. G., and ALLEN, B. J., Prog. Neutron Capture Ther. Cancer (Proc. Int. Symp.), 4th, 1990, Plenum, New York, NY, USA, publ. 1992, pp. 451–454. lids: Allen, B. J., Moore, D. E. and Harrington, B. V.
  • Regional blood flow measurement with nonradioactive microspheres. MORI, H., HARUYAMA, S., SHINOZAKI, Y., SAKAmoTo, H., OBE\To, H., TAKANASHI, R., and SAM:MA, I., Kokyu To junkan, 1992, 40, (10), 957–961.
  • Comparison of anticonvulsant effects of valproic acid entrapped in positively and negatively charged liposomes in amygdaloid-kindled rats. MORI, N., and OHTA, S., Brain Res., 1992, 593, (2), 329–331.
  • Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy. MORITERA, T., OGURA, Y., YOSHIMURA, N., HONDA, Y., WADA, R., HYON, S. H., and IKADA, Y., Invest. Ophthalmol. Vis. Sci., 1992, 33, (11), 3125–3130.
  • Stability and blood compatibility of polylipid/Hb. MORIZAWA, K., AKAMA, K., KAWAKAMI, Y., and TsucHIDA, E., Biomater. Artif. Cells Immobilization Biotechnol., 1992, 20, (2-4), 641-645. Kinetic evidence for interdigitation in model lipid bilayers. Moss, R. A., and BHATTACEIARYA, S., j. Phys. Org. Chem., 1992, 5, (8), 467–470.
  • Alkyl cyanoacrylate drug carriers: I. Physicochemical characterization of nanoparticles with different alkyl chain lengths. MUELLER, R. H., LHERM, C., HERBORT, J., BLUNK, T., and COUVREUR, P., Int. J. Pharm., 1992, 84, (1), 1–11.
  • In vitro characterization of poly(methyl methacrylate) nanoparticles and correlation to their in vivo fate. MUELLER, R. H., WALLIS, K. H., TROESTER, S. D., and KREUTER, J., y. Controlled Release, 1992, 20, (3), 237–246.
  • Kinetics of drug release from isonicotinic acid hydrazide microcapsules. MUELLER, G., and PAL, T. K., Drug Dev. Ind. Pharm., 1992, 18, (17), 1921–1925.
  • Formation and stability of lanthanide complexes and their encapsulation into polymeric microspheres. MUMPER, R. J., and JAY,Phys. Chem., 1992, 96, (21), 8626–8631.
  • Solvent effects on the formation of cross-linking microspheres in gamma-irradiated solu-tions. NAKA, Y., YAMAMOTO, Y., and HAYASHI, K., Radiat. Phys. Chem., 1992, 40, (2), 83–88.
  • Characteristics of polylipid/Hb vesicles (ARC) (in vitro and in vivo test). NAKACHI, O., TOKUYAMA, S., SATOH, T., and TSUCHIDA, E., Biornater. Artif. Cells Immobilization Biotechnol., 1992, 20, (2-4), 635–640.
  • Clinical evaluation of intermittent arterial infusion chemotherapy with an implanted reservoir for hepatocellular carcinoma. NAKAMURA, K., TAKASHIMA, S., TAKADA, K., FUJIMOTO, K., KAMINOU, T., NAKATSUKA, H., MINAKUCHI, K., and ONOYAMA, Y., Cancer Chemother. Pharmacol., 1992, 31, (Suppl.), S93–S98.
  • Preparation and in vitro evaluation of liposomes containing an antitumor pyrrolopyrimidine compound. NAZAROV, A. D., BOLOTIN, I. M., and SOKOLOVA, A. S., Novel Drug Formulation Syst. Delivery Devices, Int. Semin., 1991, Latv. State Pharm. Co. "Grindex", Riga, Latvia, publ. 1992, pp. 49–51. Ed.: Bundulis, J.
  • Evaluation of biodegradable microspheres as vaccine adjuvant for hepatitis B surface antigen. NELLORE, R. V., PANDE, P. G., YOUNG, D., and BHAGAT, H. R., J. Parenter. Sci. Technol., 1992, 46, (5), 176–180.
  • Endogenous candida endophthalmitis in a drug dependent patient: intravenous therapy with liposome encapsulated amphorericin B. NEPPER'F, B., GUTHOFF, R., and HEIDEMANN, H. T., Klin. Monatsbl. Augenheilkd., 1992, 201, (2), 122–124.
  • Association of methotrexate encapsulated in negatively charged liposomes with cells at nanomolar lipid concentrations. NG- KA-YUN, and HEATH, T. D.,9'. Liposome Res., 1992, 2, (2), 217–235.
  • Human serum albumin as a probe for surface conditioning (opsonization) of block copoly-mer-coated microspheres. NORMAN, M. E., WH,LIAms, P., and ILTum, L., Biomaterials, 1992, 13 (12), 841–849.
  • Fusion of influenza virus particles with liposomes: requirement for cholesterol and virus receptors to allow fusion with and lysis of neutral but not of negatively charged lipo-somes. NUSSBAUNI, O., ROTT, R., and LoYTER, A., y. Gen. Virol., 1992, 73, (11), 2831–2837.
  • Antitumor drug liposome form advantages. OBOROTOVA, N. A., and LUKICHEVA, M. V .,Novel Drug Formulation Syst. Delivery Devices, Int. Semin., 1991, Latv. State Pharm. Co. "Grindex", Riga, Latvia, publ. 1992, pp. 38–43. Ed.: Bundulis, J.
  • Development of a liposome-encapsulated radionuclide with preferential tumor accumula-tion-the choice of radionuclide and chelating ligand. OGIHARA-LMEDA, I., SASAKI, T., and Ntsmoom, H., Int. J. Rad. Appl. lnstrum. (B), 1992, 19, (7), 753–757.
  • Synthesis and polymerization of an aminolysolecithin-type macromer. OHKATSU, Y., SUZUKI, E., and KusAN0, T., Yakagaku, 1992, 41, (6), 465–471.
  • Effect of lipidic factors on membrane cholesterol topology. Mode of binding of theta-toxin to cholesterol in liposomes. OHNO, I. Y., IWAMOTO, M., ANDO, S., and IwAsHITA, S., Biochim. Biophys. Acta, 1992, 1109, (1), 81–90.
  • Thermo-sensitive release behavior of 5-fluorouracil from chitosan-gel microspheres coated with lipid multilayers. 01 IVA, Y., TAKE, T., and OUCH,Bioact. Compat. Polym., 1992,7, (3), 242–256.
  • Anticancer effects of chemoembolization using microspheres of an angiogenesis inhibitor (TNP-470) in rabbits bearing VX-2 carcinoma. OKADA, H., KAMEI, S., YOSHIOKA, T., IN0HE, Y., OGAWA, Y., and TOGUCHI, H., Drug Delivery Syst., 1992, 7, (2), 97–102.
  • Comparison of the potency of five potential beta-adrenoceptor blocking drugs and eight calcium channel blockers to inhibit platelet aggregation and to perturb liposomal membranes prepared from platelet lipids. ONDRIASOVA, E., ONDRIAS, K., STASKO, A., NOSAL, R., and SCOLLEI, J., Physiol. Res., 1992, 41, (4), 267–272.
  • Influence of physico-chemical parameters on the release kinetics of ketoprofen from Poly(HEMA) crosslinked microspheres. ORIENTI, I., BER'FASI, V., and ZECCHI, V., y. Pharm. Belg., 1992, 47, (4), 309–315.
  • Loading level influence on drug release from ethylene glycol dimethacrylate-crosslinked poly(2-hydroxyethyl methacrylate) microspheres. ORIENT, I., BERTASI, V., and ZECCHI, V., y. Controlled Release, 1992, 22, (2), 159–165.
  • A phase I clinical evaluation of liposome-entrapped doxorubicin (LipDox) in patients with primary and metastatic hepatic malignancy. OWEN, R. R., SELLS, R. A., GILMORE, I. T., NEW, R. R., and STRINGER, R. E., Anticancer Drugs, 1992, 3, (2), 101–107.
  • Disposition kinetics of phospholipid liposomes. PALATINI, P., Adv. Exp. Med. Biol., 1992, 318 (Neurobiol. Essent. Fatty Acids), 375–391.
  • In vitro effects of liposome-encapsulated amphotericin B (AmBisome) and amphotericin B-deoxycholate (Fungizone) on the phagocytic and candidacidal function of human polymorphonuclear leucocytes. PALLISTER, C. J., JOHNSON, E. M., WARNOCK, D. W., ELLIOT, P. J., and REEVES, D. F., y. Antimicrob. Chemother., 1992, 30, (3), 313–320.
  • Fusion of phospholipid vesicles induced by phospholipase D in the presence of calcium ion. PARK, J. B., LEE, T. H., and Kim, H., Biochem. Int., 1992, 27, (3), 417–422.
  • Ion-exchange albumin MC (microcapsule) of propranolol. An in vitro propranolol release evaluation. PARK-SHIN, A., KIM-K[1,-So°, and Ku-YOUNG-SOON, Nonchong-Han'guk Saenghwal Kwahak Younguwon, 1992, 49, 129–144.
  • Solvent evaporation, solvent extraction and spray drying for polylactide microsphere preparation. PAVANETTO, F., CONTI, B., GENTA, I., and GiuNcHED1, P., Int. J. Pharm., 1992, 84, (2), 151–159.
  • Liphophilic cisplatin analogues entrapped in liposomes: role of intraliposomal drug activation in biological activity. PEREZ-SOLER, R., and KHOKHAR, A. R., Cancer Res., 1992, 52, (22), 6341–6347.
  • Liposomal formulation and antitumor activity of 14-0-palmitoyl hydroxyrubicin. PEREZ-SOLER, R., and PRIEBE, W., Cancer Chemother. Pharmacol., 1992, 30, (4), 267–271.
  • Toxicity and immunogenecity of Neisseria meningitidis lipopolysaccharide incorporated into liposomes. PETROV, A. B., SEMENOV, B. F., VARTANYAN, Yu. P., ZAKIRov, M. M., TORCHILIN, V. P., TRUBETSKOI, V. S., KOSHKINA, N. V., L'vov, V. L., VERNER, I. K. et al., Infect. Immun., 1992, 60, (9), 3897–3903.
  • A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. PHILLIPS, W. T., Ruom,PH, A. S., GoiNs, B., TummoNs, J. H., KLIPPER, R., and BLUMHARDT, R., Int. J. Rad. Appl. Instrum. (B), 1992, 19, (5), 539–547.
  • Biodistribution studies of liposome encapsulated hemoglobin (LEH) studied with a newly developed 99m-technetium liposome label. PHILLIPS, W. T., RUDOLPH, A. S., GOINS, B., and KLIPPER, R., Biomater. Arti f. Cells Immobilization Biotechnol., 1992, 20, (2-4), 757–760.
  • Glucoamylase immobilization on a magnetic microparticle for the continuous hydrolysis of maltodextrin in a fluidized bed reactor. PIETERS, B. R., BARDELETTI, G., and COULET, P. R., Appl. Biochem. Biotechnol., 1992, 32, 37–53.
  • Nanometer particles synthesis in reverse micelles: influence of the size and the surface on the reactivity. PILENI, M. P., LIS1ECKI, I., MOTTE, L., and PETIT, C., Res. Chem. Intermed., 1992, 17, (2), 101–113.
  • Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. PI.ANAS, M. E., GONZALEZ, P., RODRIGUEZ, L., SANCHEZ, S., and CEvu, G., Anesth. Analg., 1992, 75, (4), 615–621.
  • Use of polymer thin-film technology for microencapsulation of transition metal compounds. POMOGAILO, A. D., BOCHKIN, A. M., and ARKHIPOV, N. P., Fiz i Tekhnol Tonkoplenoch Polimer Sistem: Mater Vses Nauch-tekhn Konf, Tashkent, 16–18 Sent, 1991, Gomel (Ch. 1), 84–86.
  • Preparation and evaluation of abietic acid microcapsules by a solvent evaporation technique. PURANIK, P. K., MANEKAR, N. C., and DORLE, A. K., y. Microencapsul., 1992, 9, (4), 425–435.
  • Biological responses to exchange transfusion with liposome-encapsulated hemoglobin. RABINOVICI, R., RUDOLPH, A. S., LIGLER, F. S., SMITH, E. F. III, and FEUERSTEIN, G., Circ. Shock, 1992, 37, (2), 124–133.
  • Release kinetics of salbutamol sulfate from wax-coated microcapsules and tableted microcapsules. RAGHUVANSHI, R. S., TRIPATIII, K. P., JAYASWAL, S. B., and SINGH, J., J. Microencapsul., 1992, 9, (4), 449–455.
  • Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells. RAHMAN, A., HUSAIN, S. R., StrmiQui, J., VERMA, M., AGRESTI, M., CENTER, M., SAFA, A. R., and GLAZER, R. I., y. Natl. Cancer Inst., 1992, 84, (24), 1909–1915.
  • Release kinetics of fluphenazine from biodegradable microspheres. RAMTOOLA, Z., CORRIGAN, O. I., and BARRETT, C. LI. Microencapsul., 1992, 9, (4), 415–423.
  • Effect of crosslinking agent on the release of an aqueous marker from liposomes sequestered in collagen and chitosan gels. RAO, K. P., and ALAMELU, S.,y. Membr. Sc., 1992, 71, (1-2), 161–167.
  • Ethrel enhances the degradation of artificial membrane vesicles (liposomes) by phospho-lipase A2 and phospholipase C. REUVENI, M., Acta Bot. Neerl., 1992, 41, (3), 283-291. Peanut agglutinin purging and magnetic microspheres. RER)DEs, E. G., BAKER, P. K., DUGUID, J. K., and CAWLEY, J. C., Prog. Clin. Biol. Res., 1992, 377, 139-146. Physicochemical modifications of liposome structures through interaction with surfactants. RIBOSA, I., GARCIA, M. T., PARRA, J. C., DE I,A MAZA, A., SANCHEZ-LEAL, J., TRULLAS, C., Tsi, A., BALAGUER, F., and PELEJER0, C., Int. J. Cosmet. Sci., 1992, 14, (3), 131–149.
  • Dihydroxy-carotenoid liposomes inhibit phototoxicity in Paramecium caudatum. RICH, M. R., DE STRULLE, R., FERRARO, G., and BRoDY, S. S., Photochem. Photobiol., 1992, 56, (3), 413–416.
  • Biogenesis of storage granules and vesicles. RINDLER, M. J Cure. Opin. Cell. Biol., 1992, 4, (4), 616–622.
  • A differential scanning calorimetric study of the effect of penetration enhancers on the thermal behavior of dipalmitoylphosphatidylcholine multilamellar liposomes. Rtu,LAN0, A., BRztu Ewicz, A., SlutooT, B., and JAMOULLE, J. C., Predict Percutaneous Penetration, IBC Tech. Serv., London, UK, publ. 1991, pp. 365–372. Ed.: Scott, R. C.
  • Toxicity and immunogenic properties of liposomal form of Vipera libetina venom. RomANovA, E. B., GELASHVILI, D. B., KOSHKINA, N. V., and Tottc 00,1N, V. P.7. Liposome Res., 1992, 2, (2), 205–216.
  • Targeted delivery of biologic and other antineoplastic agents. RowoNs0N-131:szA, G., and EPENE'FOS, A. A., Curr. Opin. Oncol., 1992, 4, (6), 1142–1148.
  • Indomethacin-loaded microspheres: design and preparation by a multiple-emulsification technique and their in vitro evaluation. Roy, S., PAL, M., and GUPTA, B. K., Pharm. Res., 1992, 9, (9), 1132–1136.
  • Reversible, nonionic, and pH-dependent association of cytochrome c with cardiolipin-phosphatidylcholine liposomes. RrEOMAA, M., MUSTONEN, P., and KINNUNEN, P. K., y. Biol. Chem., 1992, 267, (31), 22243–22248.
  • Development of technetium-99m labelled activated carbon microspheres and clinical application. SAEKI, T., KARAK I, Y., FUJIMAKI, M., MAEDA, M., and HONDA, T., I2adioakt. Isot. Klin. Forsch., 1991, 19, 315–321.
  • Controlled release of cisplatin from lactic acid oligomer microspheres incorporating cis-platin: in vitro studies. SAKAKURA, C., TAKAHASHI, T., HAGIWARA, A., ITtui, M., SASABE, T., LEE, M., and SHOBAYASIII, S., y. Controlled Release, 1992, 22, (1), 69–74.
  • Light-induced coupling of aqueous-soluble proteins to liposomes formed from carbene-generating phospholipids. SANGER, M., 13010,E, F., HEI,I,ER, M., and SIGRIsT, H., Bioconjug. Chem., 1992, 3, (4), 308–314.
  • Interaction between liposomes as a model of biomembrane and nonionic surfactants. SASAKI, I., SUZUKI, T., and 'sum, F., Yukagaku, 1992, 41, (10), 1055–1060.
  • Characteristics of artificial red cells. Hemoglobin encapsulated in poly-lipid vesicles. SATOH, T., KOBAYASHI, K., SEKIGUCHI, S., and TSUCHIDA, E., ASAIO Y., 1992, 38, (3), M580–M584.
  • Poly(ethylene oxide)-graft-poly(L-lysine) copolymers to enhance the biocompatibility of poly(L-lysine)-alginate microcapsule membranes. SAWDNEY, A. S., and HUBBELL, J. A., Biomaterials, 1992, 13, (12), 863–870.
  • Interactions of aminoglycoside antibiotics with phospholipids. A deuterium nuclear magnetic resonance study. SCHANCK, A., MINGE0T-LEcLERCQ, M. P., Tui,KENS, P. M., CARRIER, D., SMITH, I. C., and JARRELI„ H. C., Chem. Phys. Lipids, 1992, 62, (2), 153–163.
  • Polyethylene-glycol-mediated delivery of liposome-entrapped pigments into fibroblasts: experimental pigment cells as models for mutator phenotypes. SCHMITZ, S., ALLEN, 'I'. M., and Jr‘thow, K., Cancer Res., 1992, 52, (23), 6638–6645.
  • Labelling of liposomes with intercalating perylene fluorescent dyes. SCHOTT, 11., VON CUNOW, D., and LANGHALS, H., Biochim. Biophys. Acta, 1992, 1110, (2), 151-157. Liposome aerosols. SCHREIER, H.J. Liposome Res., 1992, 2, (2), 145–184.
  • An adapter for defined sample volumes makes it possible to count absolute particle numbers in flow cytometry. SCHWEPPE, F., HAUSNIANN, M., HEXEL, K., BAR'I'HS, J., and CREMER, C., Anal. Cell. Pathol., 1992, 4, (4), 325–334.
  • Microencapsulation of mammalian cells in a biocompatible polyacrylate: a progress report. SEF"roN, M., KHARLIP, L., HORVATH, V., and ULUDAG, H., Polym. Med., Technomic., Lancaster, Pa, 1992, pp. 1–11. Eds: Ottenbrite, R. M. and Chiellini, E.
  • Model studies directed toward the boron neutron-capture therapy of cancer: boron delivery to marine tumors with liposomes. SHELLY, K., FEARER, D. A., HAWTHORNE:, M. F., SCHMIDT, P. G., KRISCH, T. A., and BAUER, W. F., Proc. Natl. Acad. Sci. USA, 1992, 89, (19), 9039–9043.
  • Liposomal delivery of boron for BNCT. SHELLY, K., HAWTHORNE, M. F., and SCHMIDT, P. G., Prog. Neutron Capture Ther. Cancer (Proc. Int. Symp.), 4th, 1990:, Plenum, New York, NY, USA, publ. 1992, pp. 259–264. Eds: Allen, B. J., Moore, D. E. and Harrington, B. V.
  • Nanoparticulate alumina, silica and aluminosilicate membranes. SHENG-GUANGYAO, CHU-LOON, ZELTNER, W. A., and ANDERSON, M. A., y. Non-Cryst. Solids, 1992, 147–148. 548–553.
  • Targeting cancer chemotherapy using temperature-sensitive liposomes containing adria-mycin conjugated with monoclonal antibodies. SHIBATA, S., KUMAI, K., TAKAHASHI, T., MURAYAMA, Y., ISHIBIKI, K., and KITAJIMA, M., Gan To Kagaku Ryoho, 1992, 19, (10, Suppl.), 1671–1674.
  • Increase in water permeability of negatively charged liposomal membrane by local anesthetics. SHIMOOKA, T., SEED, S., and TERADA, H., Chem. Pharm. Bull., 1992, 40, (7), 1880–1882.
  • Nanoparticles as drug carriers for vinblastine. Acute toxicity of vinblastine in a free form and associated to polybutylcyanoacrylate nanoparticles. SIMEONOVA, M., ILARIONOVA, M., IVANOVA, T., KONSTANTINOV, C., and T00020v, D., Acta Physiol. Pharmacol. Bulg., 1991, 17, (4), 43–49.
  • Immunogenicity studies on diphtheria toxoid-loaded biodegradable microspheres. SINGH, M., SINGH, O., SINGH, A., and TAMAR, G. P., Int. J. Pharm., 1992, 85, (1-3), R5–R8.
  • Preparation of submicron drug particles in lecithin-stabilized o/w emulsions: I. Model studies of the precipitation of cholesteryl acetate. SJOESTROEM, B., and BERGENSTAAHL, B., Int. y. Pharm., 1992, 84, (2), 107–116.
  • Hormonocytostatic liposome forms. Antitumor activity. SMIRNOVA, Z. S., KULAGINA, T. F., 013()K0T0vA, N. A. LLTKICHEVA, M. V., OKSINOID, O. E., and AFONIN, N. I., Novel Drug Formulation Syst. Delivery Devices, Int. Semin., 1991, Latv. State Pharm. Co. "Grindex", Riga, Latvia, publ. 1992, pp. 44–48. Ed.: Bundulis, J.
  • Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. S00N-SHI0ND, P., FELDMAN, E., NELSON, R., KOMTEBEDDE, J., SMIDSROD, O., SKJAK-BRAEK, G., ESPEVIK, T., HEINTZ, R., and LEE, M., Transplantation, 1992, 54, (5), 769–774.
  • Glucose-insulin kinetics of the extravascular bioartificial pancreas. A study using micro-encapsulated rat islets. SOON-SDIDNG, P., HEINTZ, R., YAO, Z., YAO Q., SANFORD, P., LANZA, R. P., and MEREDITH, N., ASAIO y., 1992, 38, (4), 851–854.
  • Quantitative reconstitution of isolated influenza haemagglutinin into liposomes by the detergent method and the immunogenicity of haemagglutinin liposomes. STAIIN, R., SCHAFER, H., KUNZE, M., MALUR, J., LADHOFF, A., and LACHMANN, U., Acta Virol. (Praha), 1992, 36, (2), 129–144.
  • Prevention of postischemic lesions of the myocardium using liposomes. STEFANOV, A. V., KHROMOV, A. S., ZHUKOVA, A. V., SAGACII, V. F., IvAT, O. D., and LISHKO, V. K., Biull. Eksp. Biol. Med., 1992, 113, (6), 590–593.
  • Persistence of increased cholesteryl ester in human skin fibroblasts is caused by residual exogenous sphingomyelinase and is reversed by phospholipid liposomes. STEIN, O., OETTE, K., DABACH, Y., HOLLANDER, O., BEN-NAIM, M., and STEIN, Y., Biochim. Biophys. Acta, 1992, 1165, (2), 153–159.
  • In vitro and in vivo evaluation of microencapsulated porcine islets. SUN, A. M., VACEK, I., SUN, Y. L., MA, X., and ZHou, D., ASA/0 J., 1992, 38, (2), 125–127.
  • Protective effect of liposome-associated alpha-tocopherol against paraquat-induced acute lung toxicity. SUNTRES, Z. E., HEPWORTH, S. R., and SHEK, P. N., Biochem. Pharmacol., 1992, 44, (9), 1811–1818.
  • Interaction of cholera toxin B-subunit with liposomes containing ganglioside GM1 and fluorescence-labeled lipids. SURIN, A. M., ASTASHKIN, E. I., SmiKNüv, O. N., MIKHALEV, I. I., MOIA)TKOVSKII, Y. G., and BERGEI;SON, L. D., Biol. Membr., 1992, 9, (5), 495–508.
  • In vitro oral mucosal absorption of liposomal triamcinolone acetonide. SVEINSSON, S. J., and MEZEI, M., Pharm. Res., 1992, 9, (10), 1359–1361.
  • Theoretical analysis of microcapsule mass transport behavior. SVORODA, G. D., Zilou, J., CHENG, P. S., AsiE, M., DISTELRATH, D. L., and THIES, C.,J. Controlled Release, 1992, 20, (3), 195–199.
  • Phagocytosis of polymeric microspheres. TABATA, Y., and IKADA, Y., High Perform. Biomater., Technomic, Lancaster, Pa, 1991, pp. 621–646. Ed.: Szycher, M.
  • Poly(lactic/glycolic acid) microspheres containing antigen as a novel and potential agent of immunotherapy for allergic disorders. TAKAGI, I., NISHIMURA, J., ITOH, H., BABA, S., KuNimATsu, M., and SASAKI, M., Arerugi, 1992, 41, (9), 1388–1397.
  • Oxygen-transport and solution properties of polylipid/Hb vesicles (ARC). TAKEOKA, S., HASEGAWA, E., NISHIDE, H., TsucHIDA, E., and SEKIGUCHI, S., Biomater. Artif. Cells Immobi-lization Biotechnol., 1992, 20, (2-4), 399–404.
  • The influence of the molar ratio of cholesteryl hemisuccinate/dipalmitoylphosphatidyl-choline on `liposome' formation after lipid film hydration. TALsmA, H., GOORIS, G., V. STEENBERGEN, M. J., SALomoNs, M. A., BOUWSTRA, J., and CROMMEIAN, D. J., Chem. Phys. Lipids, 1992, 62, (2), 105–112.
  • Eukaryotic cells grown on microcarrier beads offer a cost-efficient way to propagate Chlarnydia trachomatis. TAM, J. E., KNIGHT, S. T., DAVIS, C. H., and WYRICK, P. B., Biotechniques, 1992, 13, (3), 374–378.
  • Recombinant human tumor necrosis factor-beta entrapped in liposomes formed by a modification of the dehydration-rehydration method retains potent cytotoxic activity on L929 cells in vitro. TAN, L., GOH, C. R., and PORTER, A. G., jpn. J. Pharmacol, 1992, 59, (2), 235–238.
  • In vitro activity of pharmacological compounds carried by lipidic microparticles. TARAMEIAA, D., MALABARBA, M. G., Rossi, P., GRANUCCI, C., and GHIONE, M., Pharmacol. Res., 1992, 26, (Suppl. 2), 126–127.
  • Nonselective interactions of Concanavalin A with phosphatidylcholine small unilamellar vesicles: implications for chemical sensor development. TAUSKELA, J. S., and THOMPSON, M., Anal. Chim. Ada, 1992, 264, (2), 185–188.
  • The effect of lipase on the release of naltrexone from triglyceride-coated cellulose acetate phthalate microspheres. TEFFT, J. A., Rosxos, K. V., and HELLER, J., y. Biomed. Mater. Res., 1992, 26, (6), 713–724.
  • Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity. THIERRY, A. R., and DRiTscui L.°, A., Nucleic Acids Res., 1992, 20, (21), 5691–5698.
  • Effect of liposomes on P-glycoprotein function in multidrug resistant cells. THIERRY, A. R., DRITSCHILO, A., and RAHMAN, A., Biochem. Biophys. Res. Commun., 1992, 187,(2), 1098–1105.
  • Liposomes as carriers for poorly soluble drugs in injectable solutions. Part 1. Influence of composition upon mean diameter and homogeneity of liposomes prepared by the detergent-dialysis method. THOMA, K., and SCHMID, A., Eur. y. Pharm. Biopharm., 1992,38, (2), 61–65.
  • Ascorbate and phenolic antioxidant interactions in prevention of liposomal oxidation. THOMAS, C. E., MCLEAN, L. R., PARKER, R. A., and OHLWEILER, D. F., Lipids, 1992, 27, (7), 543–550.
  • The design of liposomal paramagnetic MR agents: effect of vesicle size upon the relaxivity of surface-incorporated lipophilic chelates. Tit,cocK, C., AFIKONG, Q. F., KOENIG, S. H., BROWN, R. D., DAVIS, M., and KABALKA, G., Magn. Reson. Med., 1992, 27, (1), 44–51.
  • Microparticles of polyvinyl alcohol for nasal delivery. I. Generation by spray-drying and spray-desolvation. TING, T. Y., GONDA, I., and GIPPS, E. M., Pharm. Res., 1992, 9, (10), 1330–1335.
  • Preparation and in vitro antiviral activity of liposomes of lipophilic esters of acyclovir. TONG, P., Hou, X. P., SHAO, S., ZHANG, Y. M., and ZHANG, C. H., Yao Hsueh Hsueh Pao, 1992, 27, (1), 15–21.
  • Temperature-dependent aggregation of pH-sensitive phosphatidylethanolamine-oleic acid-cholesterol liposomes as measured by fluorescent spectroscopy. TORCHILIN, V. P., OMELYANENKO, V. G., and LUKYANOV, A. N., Anal. Biochem., 1992, 207, (1), 109–113.
  • Correlation of the surface hydrophobicity of 14C-poly(methyl methacrylate) nanoparticles to their body distribution. TROESTER, S. D., WALLIS, K. H., MUELLER-RAINER, H., and KREUTER, J., J. Controlled Release, 1992, 20, (3), 247–260.
  • Microsphere encapsulated 1-ascorbic acid: its effects on erythrocytes during 56 days storage. TRUTER, E. J., Biomater. Artif. Cells Immobilization Biotechnol., 1992, 20, (2-4), 1107-1109. Synthesis and characterization of artificial red cell (ARC). TSUCHIDA, E., Biomater. Artif. Cells Immobilization Biotechnol., 1992, 20, (2-4), 337–344.
  • Liposomes containing muramyl tripeptide phosphatidylethanolamine (MTP-PE) are excellent adjuvants for induction of an immune response to protein and tumor antigens. ULLRICH, S. E., and FIDLER, I. J., y. Leukoc. Biol., 1992, 52, (5), 489–494.
  • Nitrogen-filled liposomes as a vascular US contrast agent: preliminary evaluation. UNGER, E. C., LUND, P. J., SHEN, D. K., FRITZ, T. A., YELLOWHAIR, D., and NEW, T. E., Radiology, 1992, 185, (2), 453–456.
  • Study of effect of the newly developed artificial blood "Neo Red Cells (NRC)" on hemo-dynamics and blood gas transport in canine hemorrhagic shock. USUBA, A., MOTOKI, R., SUZUKI, K., SAKAGUCHI, K., and TAKAHASHI, A., Biomater. Arti f. Cells Immobilization Biotechnol., 1992, 20, (2-4), 531–535.
  • Liposomes targeted to deliver antisecretory agents to jejunal mucosa. UWIERA, R. R. E., ROMANCYIA, D. A., WONG, J. P., and FORSYTH, G. W., Can. J. vet. Res., 1992, 56, (3), 249–255.
  • Pharmacokinetics of liposome-entrapped cis bis(neodecanoato-trans-R,R-1,2-diaminocyclo-hexane)platinum(II) and cisplatin given i.v. and i.p. in the rat. VADIEI, K., SIDDIK, Z. H., KOKHAR, A. R., AL-BAKER, S., SAMPEDRO, F., and PEREZ-SOLER, R., Cancer Chemother. Pharmacol., 1992, 30, (5), 365–369.
  • In vivo distribution and antitumor activity of liposomal 3',5'-0-dipalmitoy1-5-fluoro-2'-deoxyuridine. VAN-BORSSUM-WAALKES, M., FICHTNER, I., DONTJE, B., LEmm, M., BECKER, M., ARNDT, D., and SCFIERPHOF, G. L., y. Microencapsul., 1992, 9, (3), 335–346.
  • Effects of the anesthetic dibucaine on the kinetics of the gel-liquid crystalline transition of dipalmitoylphosphatidylcholine multilamellar vesicles. VAN °spot., W. W., YE-QIANG, JOHNSON, M. L., and BILTONEN, R. L., Biophys. y., 1992, 63, (4), 1011–1017.
  • Laser mediated release of dye from liposomes. VANDERMEULEN, D. L., MisRA, P., MICHAEL, J., SPEARS, K. G., and KHOKA, M., Photochem. Photobiol., 1992, 56, (3), 325–332.
  • Reduction of systemic exposure and toxicity of cisplatin by encapsulation in poly-lactide-co-glycolide. VERRIJK, R., SMOLDERS, I. J., BOSNIE, N., and BEGG, A. C., Cancer Res., 1992, 52, (23), 6653–6656.
  • Microencapsulation of solid dispersions: release of griseofulvin from griseoful-vin phospholipid coprecipitates in microspheres. VUDATHALA, G. K., and ROGERS, J. A., Pharm. Res., 1992, 9, (6), 759–763.
  • Bioadhesive polymer-grafted starch microspheres bearing isosorbide dinitrate for buccal administration. VYAS, S. P., and JAIN, C. P., J. Microencapsul., 1992, 9, (4), 457–464.
  • Conformations of dibucaine and tetracaine in small unilamellar phosphatidylcholine vesicles as studied by nuclear Overhauser effects in proton nuclear magnetic resonance spectroscopy. WÄKITA, M., KURODA, Y., FUJIWARA, Y., and NAKAGAWA, T., Chem. Phys. Lipids, 1992, 62, (1), 45–54.
  • Drug encapsulation in alginate microspheres by emulsification. WAN, L. S., HENG, P. W., and CHAN, L. W., J. Microencapsul., 1992, 9, (3), 309–316.
  • Process and formulation variables in the preparation of biodegradable microspheres by the solvent evaporation method (I): W/O/W multiple emulsion technique for water-soluble drugs. WANG-CHAO-JIH, KL30-PEI-CHUNG, and TIEN-JUNG-HSIUNG, Zhonghua Yaoxue Zazhi, 1992, 44, (3), 199–210.
  • Factors affecting in vivo stability of liposomes. WANG-DONGKAI, WANG-CHUNXIANG, ZHANG-QINGMIN, and GU-XuEQiu, Shenyang Yaoxueyuan Xuebao, 1992, 9, (1), 75–78.
  • Preparation and application of poly(vinylamine)/alginate microcapsules to culturing of a mouse erythroleukemia cell line. WANG, F. F., Wu, C. R., and WANG, Y. J., Biotechnol. Bioeng., 1992, 40, (9), 1115–1118.
  • An approach to the preparation of digestive enzymes for oral administration: enteric-soluble disacchridase microcapsules. WANG-XIAOLU, and YE-7,Hu, Zhongguo Yixue Kexueyuan Xuebao, 1992, 14, (2), 155–158.
  • Studies on pharmacokinetics of cisplatin-ethylcellulose microspheres for maxillary arterial embolization in dogs. WEI, S. L., Q1, X. R., and YANG, J., Yao Hsueh Hsueh Pao, 1992,27, (5), 381–384.
  • Protective effects of an oral microencapsulated Mycoplasma hyopneumoniae vaccine against experimental infection in pigs. WENG, C. N., TZAN, Y. L., Liu, S. D., LIN, S. Y., and LEE, C. J., Res. Vet. Sci., 1992, 53, (1), 42–46.
  • Physicochemical characterization of a model intravenous oil-in-water emulsion. WEsTlisEN, K., and WEHLER, T., y. Pharm. Sci., 1992, 81, (8), 777,-786. Membrane fusion. WHITE, J. M., Science, 1992, 258, (5084), 917–924.
  • Liposomes and the pro-liposome method. WILLIAMS, P., Seifen, Ode, Fette, Wachse, 1992, 118, (6), 377–378.
  • Doxorubicin-loaded casein microspheres: protein nature of drug incorporation. Wit,Lmorr, N., MAGEE, G. A., CUMMINGS, J., HALBERT, G. W., and SMYTH, J. F., J. Pharm. Pharmacol., 1992, 44, (6), 472–475.
  • Liposome potentiation of humoral immune response to lipopolysaccharide and O-poly-saccharide antigens of Brucella abortus. WONG, J. P., CHERWONOGRODZKY, J. W., Dr NINNO, V. L., STADNYK, L. L., and KNODEL, M. H., Immunology, 1992, 77, (1), 123–128.
  • Immunomagnetic particle induced lysis of antibody-conjugated liposomes. WRIGHT, S. E., and HUANG, L., y. Liposome Res., 1992, 2, (2), 257–273.
  • Adhesion kinetics of phosphatidylcholine liposomes by evanescent wave light scattering. XIA-ZHEMING, and VAN DE VEN, T. G. M., Langmuir, 1992, 8, (12), 2938–2946.
  • The preparation and stability of liposome-encapsulated Ara-A. XcE, Y. Y., and WENG, G. Y., Yao Hsueh Hsueh Pao, 1992, 27, (1), 74–80.
  • When lipid bilayers won't form liposomes: tubules, helixes, and cochleate cylinders. YAGEI2, P., CHAPPELL, J., and ARCIIIIIALD, D. D., Biomembr. Struct. Funct. State of the Art, Proc. Indo-US Workshop, 1991, Adenine Press, Schenectady, NY, USA, publ. 1992, pp. 1–19. Eds: Gaber, B. P. and Easwaran, K. R. K.
  • Preparation of neurotensin analogue-containing poly(dl-lactic acid) microspheres formed by oil-in-water solvent evaporation. YAMAKAWA, I., TSUSHIMA, Y., MACHIDA, R., and WATANABE, 5., y. Pharm. Sci., 1992, 81, (9), 899–903.
  • In vitro and in vivo release of poly(m-lactic acid) microspheres containing neurotensin analogue prepared by novel oil-in-water solvent evaporation method. YANIAKAWA, I., TSUSHIMA, Y., MACHIDA, R., and WATANABE, s., y. Pharm. Sri., 1992, 81,(8), 808–811.
  • Synthesis of antibiotic-loaded hydroxyapatite beads and in vitro drug release testing. Y.AIVIAMURA, K., IwATA, H., and YOTSUYANAGI, T., J. Biomed. Mater. Res., 1992, 26, (8), 1053–1064.
  • Freezing behaviour of microencapsulated water. YAMANE, H., 011SHINIA, H., and Ko Do, T., .7. Microencapsul., 1992, 9, (3), 279–286.
  • Phase transitions of phospholipid vesicles under osmotic stress and in the presence of ethylene glycol. YAMAZAKI, M., OHSHIKA, M., KASHIWAGI, N., and ASANO, T., Biophys. Chem., 1992, 43, (1), 29–37.
  • Application of boronated anti-CEA immunoliposome to boron neutron capture therapy. YANAGIE, H., FUJII, Y., TomiTA, T., NARIUCHI, H., SEKIGUCHI, M., and KOBAYASHI, H., Prog. Neutron Capture They. Cancer (Proc. Int. Symp.), 4th, 1990, Plenum, New York, NY, USA, publ. 1992, pp. 273–275. Eds: Allen, B. J., Moore, D. E. and Harrington, B. V.
  • Fundamental studies on development of a new drug delivery system employing magnetic microspheres with different surface properties. YANASE, N., ASAKURA, H., and SUZUTA, T., Tokyo Ika Daigaku Zasshi, 1992, 50, (4), 537–544.
  • Antitumor effect of liposome-entrapped carboplatin after intraperitoneal administration in rats. YASUI, T., MIZUNO, 1., ICHINO, T., AKAmo, Y., YAMAMOTO, T., ITABASHI, Y., SAIT0, T., KURAHASHI, S., TANimoTo, N., YURA, J. et al., Can To Kagaku Ryoho 19, (10, Suppl.), 1753-1755.
  • Block copolymers as drug carriers. YOKOYAMA, M., Crit. Rev. Ther. Drug. Carrier Syst., 1992, 9, (3-4), 213–248.
  • Metabolic fate of ("C)triglyceride-entrapped lactosylceramide-bearing liposomes after intravenous injection into mouse. YOSHIOKA, S., BANNO, Y., OKANO, Y., OHKI, K., and MIZUKAMI, Y., Chem. Pharm. Bull., 1992, 40, (4), 1016–1021.
  • Emulsion copolymerization of styrene-chloromethylstyrene-acrylic acid latex microspheres. ZHANG-XIANMING, and SUN-ZONGHUA, Yingyong Huaxue, 1992, 9, (4), 13–16.
  • Effect of the final stage of processing on the properties of microcapsule coatings from natural polyelectrolytes. Z0F.LEzN0v, K. N., INDEIKIN, E. A., SIBRINA, G. V., and BASAEVA, YA V., lzv. Vyssh. Uchebn. Zaved. Khim. Khim. Tekhnol., 1992, 35, (6), 88–93.
  • Liposome-encapsulated he moblobin processing methods. ZHENG, S., ZHENG, Y., BEISSINGER, R. L., and FRESCO, R., Biomater. Artif. Cells Immobilization Biotechnol., 1992, 20, (2–4), 355–364.
  • Prolonged survival of thymoma-bearing mice after vaccination with a soluble protein antigen entrapped in liposomes: a model study. ZHOU, F., RousE, B. T., and HUANG, L., Cancer Res., 1992, 52, (22), 6287–6291.
  • New developmental tendencies for the encapsulation of (cosmetic) products and active ingredients. ZIOLKOWSKY, B., Selfen, Oele, Fette, Wachse, 1992, 118, (3), 172, 174, 176, 178, 180.
  • The quantitative analysis of adriamycin and liposome encapsulated adriamycin injected into hepatic artery in vivo. ZOU-YIYU, GU-XUEQIU, UENO, M., and HoRixosm, I., Shenyang Yaoxueyuan Xuebao, 1992, 9, (1), 6–9.
  • Conventional vs. liposomal amphotericin B in immunosuppressed children (letter). ZOUBEK, A., EMMINGER, W., EMMINGER-SCHMIDMEIER, W., PETERS, C., PRACHER, E., GROIS, N., and GADNER, H., Pediatr. Hematol. Oncol., 1992, 9, (2), 187–190.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.